VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

9.50$ -0.7% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in SEK.

Tick rows to compare them in a chart (up to 4)

Income Statement VCRE
Line item	2022	2023	2024	2025
Revenue	0.00	0.00	0.47	0.01
Gross Profit	0.00	0.00	0.47	0.01
Research & Development	2.97	2.41	1.06	1.39
Selling, General & Administrative	0.45	0.39	0.22	0.24
Total Operating Expenses	3.42	2.79	1.28	1.63
Operating Income	-3.42	-2.79	-0.81	-1.61
Interest Expense	0.00	0.00	0.00	0.00
Pre-Tax Income	-3.43	-2.71	-0.72	-1.70
Net Income	-3.43	-2.71	-0.72	-1.70

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.